drugset / Trial / NCT07805707

A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age

NCT07805707 ↗

Phase 3 Recruiting 54000 enrolled GlaxoSmithKline
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study will compare an investigational mRNA flu vaccine with a licensed flu vaccine in adults 65 years of age and older. Participants will receive one injection and will be followed during the flu season. The study will measure prevention of laboratory-confirmed flu illness, side effects, and immune responses.

Timeline

Start
2026-09-02
Primary completion
2028-06-09
Completion
2028-06-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Licensed influenza vaccine Vaccine — Intramuscular
Subject mRNA Seasonal Flu vaccine Messenger RNA (mRNA) — Intramuscular

Indications